Announcement

Date Time Subject
2025/04/2316:55:49Announcement of Medeon’s fund loans and over-limit improvement plan
2025/04/2316:48:04Medeon Biodesign’s Board of Directors approved incremental investment to its subsidiary PMC
2025/04/1515:19:47Medeon, on behalf of its subsidiary PMC, announces the board resolution of record date for the cash capital increase and other related matters
2025/04/1515:09:54Medeon, on behalf of its subsidiary PMC, announces the material resolutions at the 2025 the 1st Extraordinary Shareholders’ Meeting.
2025/03/3116:23:32Medeon, on behalf of its subsidiary PMC, announces the resolution of BOD on the issuance of Series E Preferred Stocks
2025/03/1620:29:18Medeon is invited to attend the investor conference held by MasterLink Securities
2025/02/2718:15:30BOD of Medeon’s major subsidiary PMC resolved to convene the 2025 Annual Shareholders’ meeting
2025/02/2718:10:10BOD of Medeon’s major subsidiary PMC resolved not to distribute dividends
2025/02/2718:05:16BOD of Medeon’s major subsidiary Medeologix Corporation resolved to convene the 2025 Annual Shareholders’ meeting
2025/02/2718:00:13BOD of Medeon’s major subsidiary Medeologix Corporation resolved not to distribute dividends